Flow diversion for intracranial aneurysms emerged as an efficacious and durable treatment option over the last two decades. In a paradigm shift from intrasaccular aneurysm embolization to parent vessel remodeling as the mechanism of action, the proliferation of flow-diverting devices has enabled the treatment of many aneurysms previously considered untreatable. In this review, we review the history and development of flow diverters, highlight the pivotal clinical trials leading to their regulatory approval, review current devices including endoluminal and intrasaccular flow diverters, and discuss current and expanding indications for their use. Areas of clinical equipoise, including ruptured aneurysms and wide-neck bifurcation aneurysms, are summarized with a focus on flow diverters for these pathologies. Finally, we discuss future directions in flow diversion technology including bioresorbable flow diverters, transcriptomics and radiogenomics, and machine learning and artificial intelligence.
BACKGROUND: The optimal endovascular management of cervical carotid dissection causing tandem occlusion remains uncertain. We investigated the impact of emergent carotid stenting during endovascular treatment for acute ischemic stroke in patients with tandem occlusion secondary to cervical carotid artery dissection. METHODS: This was a secondary analysis of patients treated with endovascular treatment for acute ischemic stroke due to occlusive carotid artery dissection and tandem occlusion included in the retrospective international STOP-CAD study (Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection). We compared patients with and without emergent stenting. The primary efficacy and safety outcomes were 90-day functional independence (modified Rankin Scale score, 0–2) and symptomatic intracranial hemorrhage within 24 hours after endovascular treatment. Procedural outcome was successful intracranial recanalization (modified Thrombolysis in Cerebral Infarction score of 2b/3). We used mixed-effects logistic regression adjusting for site, age, and National Institutes of Health Stroke Scale. In additional analyses, we used inverse probability of treatment weighting and adjusted for Alberta Stroke Program Early CT Score. RESULTS: Of the 4023 patients enrolled in STOP-CAD, 328 presented with anterior circulation acute ischemic stroke due to tandem occlusion and underwent endovascular treatment. The median age was 51 (interquartile range, 44–58) years, and 96 patients (29.3%) were female. One hundred fifty patients (45.7%) underwent emergent stenting. There was no significant association between stenting and 90-day functional independence (62.0% versus 59.7%; adjusted odds ratio, 1.23 [95% CI, 0.82–1.86]; P =0.315) or symptomatic intracranial hemorrhage (7.3% versus 7.9%; adjusted odds ratio, 0.95 [95% CI, 0.41–2.2]; P =0.913). Emergent carotid stenting was associated with successful intracranial recanalization (81.8% versus 76.6%; adjusted odds ratio, 2.62 [95% CI, 1.52–4.5]; P <0.001). Results did not meaningfully change in additional analyses. CONCLUSIONS: In patients presenting with an acute anterior circulation tandem occlusion secondary to cervical carotid artery dissection, emergent stenting was associated with a higher likelihood of successful intracranial recanalization but not improved functional outcomes or increased symptomatic intracranial hemorrhage. It remains unclear whether emergent stenting led to successful intracranial recanalization or patients with successful intracranial recanalization were more likely to be stented. Randomized trials are warranted.
28 February 2025 in Surgical Neurology International
Background: The endovascular treatment of complex middle cerebral artery (MCA) aneurysms, particularly dysplastic large MCA bifurcation aneurysms, can pose significant technical challenges. We aim to present three cases illustrating the technical nuances and challenges often encountered in Y-stent-assisted coiling (Y-SAC) for such aneurysms and provide an update on technical nuances. Methods: We present three consecutive cases of dysplastic MCA aneurysms, each >10 mm with a wide neck. We successfully performed Y-SAC in all cases on the first attempt using the “around the world” technique and used Neuroform Atlas Stent (Stryker Neurovascular, California, USA) as a distal anchor to reduce the microcatheter loop. Immediate final digital subtraction angiography showed adequate occlusion of all aneurysms. Results: All patients tolerated the procedure well and were discharged home on postoperative day (POD) 1 in all cases. The first patient required a second coiling at the aneurysm neck 6 months after initial treatment, with complete protection of the dome. The second patient’s 6-month follow-up angiogram showed complete occlusion of the aneurysm with patency of all MCA branches. Unfortunately, the third patient failed to comply with dual antiplatelet therapy after discharge and developed stent thrombosis 3 months postprocedure and passed away. Conclusion: Y-SAC is a reasonable option for large, wide-neck, MCA bifurcation aneurysms in patients who are not fit for microsurgical clipping and/or bypass surgery. Complex endovascular techniques, including aneurysm encircling and the “Atlas Stent Anchor” technique, may be necessary to complete the procedure successfully.
20 October 2024 in Journal of NeuroInterventional Surgery
Middle meningeal artery embolization (MMAE) is an effective adjunctive treatment for chronic subdural hematomas and carries a low risk of significant complications.1 Here we describe the management of a retained and fractured microcatheter following liquid embolic MMAE. A patient with chronic recurrent subdural hematomas underwent bilateral MMAE with Onyx liquid embolic material (Medtronic). The Headway Duo (Microvention) microcatheter was placed in a small distal frontal branch of the middle meningeal artery to aid in reflux into the posterior middle meningeal artery branches. Following successful MMAE, the microcatheter became trapped within the Onyx cast and, on attempted removal, the microcatheter fractured, resulting in a retained fragment extending from the middle meningeal artery cast to the guide catheter in the common carotid artery. To retrieve the fractured microcatheter, a stent retriever was deployed and resheathed multiple times until the retained microcatheter became visibly entangled with the stent retriever. Next, the stent retriever was pulled back into the guide catheter and continuous aspiration was performed through the guide catheter, and the fragmented microcatheter was successfully removed in entirety. Final angiography demonstrated no further catheter fragments, vessel damage, extravasation, flow limitation, or thromboembolic complications. Methods to avoid the complication include using a detachable tip microcatheter, dual lumen balloon microcatheter, allowing less reflux, embolizing from a larger caliber branch, and a slower microcatheter pull. Additional methods for managing the complication include using a snare, leaving the retained microcatheter and putting the patient on aspirin, and carotid stenting to tack the fractured portion down (video 1). Video 1 Management of a fractured microcatheter during middle meningeal artery embolization: This case demonstrates the successful use of a stent retriever and aspiration to retrieve a retained and fractured microcatheter following liquid embolic MMAE.
19 January 2025 in Journal of NeuroInterventional Surgery
Background Mechanical thrombectomy (MT) significantly improves outcomes in patients with acute ischemic stroke due to large vessel occlusion. There is limited understanding of how the site of hospital readmission after MT influences patient outcomes. Addressing this gap may be important for optimizing post-MT care and improving long-term outcomes for stroke patients. Methods We conducted a retrospective cohort analysis using data from the Nationwide Readmissions Database, focusing on acute ischemic stroke patients who underwent MT between 2016 and 2019. Multivariable Cox regression and Fine and Gray competing risks models were used to assess the impact of readmission site on patient outcomes, including mortality and the likelihood of discharge to home. Results The analysis included 18 330 patients readmitted within 90 days post-MT, with 63.7% readmitted to index hospitals and 36.3% to non-index hospitals. Readmission to the index hospital was not significantly associated with mortality but was linked to a higher likelihood of discharge to home (subdistributed HR 1.22, 95% CI 1.13 to 1.32, P<0.001), a lower likelihood of longer hospital stay (OR 0.81, 95% CI 0.72 to 0.90, P<0.001), and lower hospital cost (β = −3345.25, 95% CI −5786.46 to −904.04, P=0.007). Conclusion This nationwide analysis suggests that for acute ischemic stroke patients treated with MT, readmission to index hospitals within 90 days is associated with a higher likelihood of home discharge, shorter length of stay, and lower hospital cost. Further research is warranted to better understand the underlying causes of these disparities and to enhance continuity of care for this vulnerable patient population.